Ken Griffin Spruce Biosciences, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,300 shares of SPRB stock, worth $6,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,300

Previous 9,900 44.44%

Holding current value

$6,292

Previous $7,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.51 - $0.85 $1,612 - $2,687	-3,162 Reduced 3.6%	84,715 $44,000
Q1 2024 May 15, 2024	SELL	$0.7 - $5.49 $14,254 - $111,792	-20,363 Reduced 18.81%	87,877 $69,000
Q4 2023 Feb 14, 2024	BUY	$1.04 - $2.93 $34,538 - $97,305	33,210 Added 44.26%	108,240 $317,000
Q3 2023 Nov 14, 2023	BUY	$2.04 - $2.54 $7,656 - $9,532	3,753 Added 5.27%	75,030 $169,000
Q2 2023 Aug 14, 2023	SELL	$1.92 - $2.6 $3.12 Million - $4.23 Million	-1,627,341 Reduced 95.8%	71,277 $153,000
Q1 2023 May 15, 2023	SELL	$1.15 - $3.17 $56,088 - $154,610	-48,773 Reduced 2.79%	1,698,618 $3.75 Million
Q4 2022 Feb 14, 2023	BUY	$0.99 - $1.43 $17,669 - $25,522	17,848 Added 1.03%	1,747,391 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$1.18 - $2.19 $6,006 - $11,147	5,090 Added 0.3%	1,729,543 $2.37 Million
Q2 2022 Aug 15, 2022	BUY	$1.28 - $2.23 $3,336 - $5,813	2,607 Added 0.15%	1,724,453 $3 Million
Q1 2022 May 16, 2022	SELL	$1.85 - $4.59 $9,721 - $24,120	-5,255 Reduced 0.3%	1,721,846 $3.46 Million
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.74 $60,638 - $149,383	26,025 Added 1.53%	1,727,101 $7.7 Million
Q3 2021 Nov 15, 2021	SELL	$6.01 - $11.26 $11,647 - $21,821	-1,938 Reduced 0.11%	1,701,076 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$10.12 - $17.46 $2,115 - $3,649	209 Added 0.01%	1,703,014 $19.1 Million
Q1 2021 May 17, 2021	BUY	$14.8 - $25.79 $15,066 - $26,254	1,018 Added 0.06%	1,702,805 $28.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.38 - $32.42 $26.2 Million - $55.2 Million	1,701,787 New	1,701,787 $41.4 Million

Others Institutions Holding SPRB

# of Institutions

Shares Held

16.9M

Call Options Held

26.9K

Put Options Held

59.3K

View Full List

About SPRUCE BIOSCIENCES, INC.

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $10.4M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

More about SPRB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account